|
Dr. Laura Ferro has served as our President and Chief Executive Officer and one of our directors since 1991. Dr. Ferro is also the President and Chief Executive Officer of our largest shareholder FinSirton. She also serves as Vice President of Sirton a subsidiary of FinSirton that specializes in manufacturing pharmaceutical products. Dr. Ferro is also a member of the board of directors of each of FinSirton Sirton and Foltene. From 1991 to 1997 Dr. Ferro held various executive positions at Sirton including Chief Executive Officer and Chairperson of the research and development unit. Prior to that Dr. Ferro was a practicing physician for 15 years. Dr. Ferro is the chairperson of the research committee of Europharm the European Association of Small and Medium-Sized Pharmaceutical Companies and is a member of the executive committee of Farmindustria an Italian pharmaceutical industry group. She is also the President of the Gianfranco Ferro Foundation a not-for-profit Italian organization with the mission of stimulating research education and dissemination of information on the correct use of 92 medications and adverse events of medicines. Dr. Ferro received her M.D. and Ph.D. degrees from the University of Milan and a MBA from Bocconi University in Milan in 1994. Dr. Ferro is a licensed physician. She was certified in psychiatry at the University of Milan in 1981 and in Clinical Pharmacology at the University of Milan in 1994. | 